Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Prostate Cancer Treatment and Research, Renal cell carcinoma treatment, Prostate Cancer Diagnosis and Treatment, and Epigenetics and DNA Methylation.
Bottom‐Up Selective Growth of Ultralong Organic Phosphorescence Nanocrystals with Optimized Crystal Forms for In Vivo Optical Imaging
302P: Phase II study of the efficacy and safety of BNT327/PM8002 plus systemic chemotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC)
12P: Camrelizumab plus chemotherapy (Cam-chemo) as first-line (1L) therapy for advanced squamous non-small cell lung cancer (sqNSCLC): 5y update from the phase III CameL-sq trial
Research on Reactive Power Optimization Voltage Regulation Strategy for Active Distribution Networks
The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
615MO Phase I/II study of D3S-001, a second generation KRAS G12C inhibitor in advanced/metastatic solid tumors with KRAS G12C mutations
Additional file 1 of Oral-microbiome-derived signatures enable non-invasive diagnosis of laryngeal cancers
Alterations of Gut Microbiome, Metabolome, and Lipidome in Takayasu Arteritis
Achieving Dual‐Emissive and Time‐Dependent Evolutive Organic Afterglow by Bridging Molecules with Weak Intermolecular Hydrogen Bonding
Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction
Gut microbiota dysbiosis contributes to the development of hypertension
The HOF structures of nitrotetraphenylethene derivatives provide new insights into the nature of AIE and a way to design mechanoluminescent materials